Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients
Clinical trial NCT06730009 · RECRUITING
Trial details
- NCT number
- NCT06730009
- Sponsor
- Medigen Biotechnology Corporation
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-21
- Primary completion
- 2029-01-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.